E Premkumar Reddy - Publications

Affiliations: 
Molecular Biology and Genetics Temple University, Philadelphia, PA, United States 
Area:
Molecular Biology

74 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Sato K, Padgaonkar A, Cosenza S, Baker S, Reddy R, Reddy EP, Irie HY. Abstract P5-05-04: A novel inhibitor of cancer stem cells overcomes chemotherapy resistance of triple negative breast cancers Cancer Research. DOI: 10.1158/1538-7445.Sabcs19-P5-05-04  0.718
2018 Padgaonkar A, Rechkoblit O, Vasquez-Del Carpio R, Pallela V, Venkata Subbaiah D, Cosenza SC, Baker SJ, Ramana Reddy MV, Aggarwal A, Reddy EP. Targeting protein kinase CK2 and CDK4/6 pathways with a multi-kinase inhibitor ON108110 suppresses pro-survival signaling and growth in mantle cell lymphoma and T-acute lymphoblastic leukemia. Oncotarget. 9: 37753-37765. PMID 30701029 DOI: 10.18632/Oncotarget.26514  0.758
2016 Perumal D, Kuo PY, Leshchenko VV, Jiang Z, Divakar SK, Cho HJ, Chari A, Brody J, Reddy MV, Zhang W, Reddy EP, Jagannath S, Parekh S. Dual Targeting of CDK4 and ARK5 Using a Novel Kinase Inhibitor ON123300 Exerts Potent Anticancer Activity against Multiple Myeloma. Cancer Research. PMID 26873845 DOI: 10.1158/0008-5472.Can-15-2934  0.325
2015 Reddy MV, Akula B, Jatiani S, Vasquez-Del Carpio R, Billa VK, Mallireddigari MR, Cosenza SC, Venkata Subbaiah DR, Bharathi EV, Pallela VR, Ramkumar P, Jain R, Aggarwal AK, Reddy EP. Discovery of 2-(1H-indol-5-ylamino)-6-(2,4-difluorophenylsulfonyl)-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one (7ao) as a potent selective inhibitor of Polo like kinase 2 (PLK2). Bioorganic & Medicinal Chemistry. PMID 26762835 DOI: 10.1016/J.Bmc.2015.11.045  0.315
2014 Eachkoti R, Reddy MV, Lieu YK, Cosenza SC, Reddy EP. Identification and characterisation of a novel heat shock protein 90 inhibitor ONO4140. European Journal of Cancer (Oxford, England : 1990). 50: 1982-92. PMID 24835034 DOI: 10.1016/J.Ejca.2014.04.017  0.73
2014 Baker SJ, Ma'ayan A, Lieu YK, John P, Reddy MV, Chen EY, Duan Q, Snoeck HW, Reddy EP. B-myb is an essential regulator of hematopoietic stem cell and myeloid progenitor cell development. Proceedings of the National Academy of Sciences of the United States of America. 111: 3122-7. PMID 24516162 DOI: 10.1073/Pnas.1315464111  0.716
2014 Reddy MV, Akula B, Cosenza SC, Athuluridivakar S, Mallireddigari MR, Pallela VR, Billa VK, Subbaiah DR, Bharathi EV, Vasquez-Del Carpio R, Padgaonkar A, Baker SJ, Reddy EP. Discovery of 8-cyclopentyl-2-[4-(4-methyl-piperazin-1-yl)-phenylamino]-7-oxo-7,8-dihydro-pyrido[2,3-d]pyrimidine-6-carbonitrile (7x) as a potent inhibitor of cyclin-dependent kinase 4 (CDK4) and AMPK-related kinase 5 (ARK5). Journal of Medicinal Chemistry. 57: 578-99. PMID 24417566 DOI: 10.1021/Jm401073P  0.731
2014 Perumal D, Leshchenko VV, Kuo P, Jiang Z, Readhead B, Eden C, Athaluri Divakar SK, Zhang W, Cho HJ, Chari A, Reddy M, Reddy EP, Dudley J, Jagannath S, Parekh S. Weighted Gene Co-Expression Network Analysis (WGCNA) Identifies Highly Proliferative Myeloma Subgroup Responsive to CDK4/ARK5 Inhibition Blood. 124: 3445-3445. DOI: 10.1182/Blood.V124.21.3445.3445  0.317
2013 Reddy MV, Mallireddigari MR, Pallela VR, Cosenza SC, Billa VK, Akula B, Subbaiah DR, Bharathi EV, Padgaonkar A, Lv H, Gallo JM, Reddy EP. Design, synthesis, and biological evaluation of (E)-N-aryl-2-arylethenesulfonamide analogues as potent and orally bioavailable microtubule-targeted anticancer agents. Journal of Medicinal Chemistry. 56: 5562-86. PMID 23750455 DOI: 10.1021/Jm400575X  0.729
2012 Baker SJ, Reddy EP. CDK4: A Key Player in the Cell Cycle, Development, and Cancer. Genes & Cancer. 3: 658-69. PMID 23634254 DOI: 10.1177/1947601913478972  0.306
2012 Lieu YK, Reddy EP. Impaired adult myeloid progenitor CMP and GMP cell function in conditional c-myb-knockout mice. Cell Cycle (Georgetown, Tex.). 11: 3504-12. PMID 22918254 DOI: 10.4161/cc.21802  0.724
2012 Reddy MV, Akula B, Cosenza SC, Lee CM, Mallireddigari MR, Pallela VR, Subbaiah DR, Udofa A, Reddy EP. (Z)-1-aryl-3-arylamino-2-propen-1-ones, highly active stimulators of tubulin polymerization: synthesis, structure-activity relationship (SAR), tubulin polymerization, and cell growth inhibition studies. Journal of Medicinal Chemistry. 55: 5174-87. PMID 22587519 DOI: 10.1021/Jm300176J  0.371
2011 Reddy MV, Venkatapuram P, Mallireddigari MR, Pallela VR, Cosenza SC, Robell KA, Akula B, Hoffman BS, Reddy EP. Discovery of a clinical stage multi-kinase inhibitor sodium (E)-2-{2-methoxy-5-[(2',4',6'-trimethoxystyrylsulfonyl)methyl]phenylamino}acetate (ON 01910.Na): synthesis, structure-activity relationship, and biological activity. Journal of Medicinal Chemistry. 54: 6254-76. PMID 21812421 DOI: 10.1021/Jm200570P  0.399
2011 Oussenko IA, Holland JF, Reddy EP, Ohnuma T. Effect of ON 01910.Na, an anticancer mitotic inhibitor, on cell-cycle progression correlates with RanGAP1 hyperphosphorylation. Cancer Research. 71: 4968-76. PMID 21646468 DOI: 10.1158/0008-5472.Can-10-1603  0.366
2010 Samanta AK, Chakraborty SN, Wang Y, Schlette E, Reddy EP, Arlinghaus RB. Destabilization of Bcr-Abl/Jak2 Network by a Jak2/Abl Kinase Inhibitor ON044580 Overcomes Drug Resistance in Blast Crisis Chronic Myelogenous Leukemia (CML). Genes & Cancer. 1: 346-59. PMID 20798787 DOI: 10.1177/1947601910372232  0.407
2010 Chawla R, Procknow JA, Tantravahi RV, Khurana JS, Litvin J, Reddy EP. Cooperativity of Cdk4R24C and Ras in melanoma development. Cell Cycle (Georgetown, Tex.). 9: 3305-14. PMID 20703083 DOI: 10.4161/Cc.9.16.12632  0.58
2010 Reddy HK, Graña X, Dhanasekaran DN, Litvin J, Reddy EP. Requirement of Cdk4 for v-Ha-ras-Induced Breast Tumorigenesis and Activation of the v-ras-Induced Senescence Program by the R24C Mutation. Genes & Cancer. 1: 69-80. PMID 20634902 DOI: 10.1177/1947601909358105  0.315
2010 Abedin ZR, Ma Z, Reddy EP. Increased angiogenesis in Cdk4(R24C/R24C):Apc(+/Min) intestinal tumors. Cell Cycle (Georgetown, Tex.). 9: 2456-63. PMID 20603602 DOI: 10.4161/Cc.9.12.12055  0.74
2010 Baker SJ, Kumar A, Reddy EP. p89c-Myb is not required for fetal or adult hematopoiesis. Genesis (New York, N.Y. : 2000). 48: 309-16. PMID 20196078 DOI: 10.1002/Dvg.20619  0.485
2010 Reddy MV, Pallela VR, Cosenza SC, Mallireddigari MR, Patti R, Bonagura M, Truongcao M, Akula B, Jatiani SS, Reddy EP. Design, synthesis and evaluation of (E)-alpha-benzylthio chalcones as novel inhibitors of BCR-ABL kinase. Bioorganic & Medicinal Chemistry. 18: 2317-26. PMID 20188579 DOI: 10.1016/J.Bmc.2010.01.051  0.383
2010 Xu H, Dhanasekaran DN, Lee CM, Reddy EP. Regulation of neurite outgrowth by interactions between the scaffolding protein, JNK-associated leucine zipper protein, and neuronal growth-associated protein superior cervical ganglia clone 10. The Journal of Biological Chemistry. 285: 3548-53. PMID 19959466 DOI: 10.1074/Jbc.M109.064113  0.401
2010 Baek HJ, Pishvaian MJ, Cho KH, Mishra B, Reddy EP, Mishra L, Kim SS. Abstract LB-110: CDK4 activation is a key step in ELF alteration and haploinsufficeny ofcdk4prevents HCC formation inelf+/−mice Cancer Research. 70. DOI: 10.1158/1538-7445.Am10-Lb-110  0.364
2010 Oussenko I, Holland JF, Reddy EP, Ohnuma T. Abstract 2500: ON 01910. Na, a clinical stage anticancer mitotic inhibitor, produces prolonged hyperphosphorylation of RanGAP1•SUMO1 as a potential mechanism of G2/M arrest and apoptosis Cancer Research. 70: 2500-2500. DOI: 10.1158/1538-7445.Am10-2500  0.367
2009 Lieu YK, Reddy EP. Conditional c-myb knockout in adult hematopoietic stem cells leads to loss of self-renewal due to impaired proliferation and accelerated differentiation. Proceedings of the National Academy of Sciences of the United States of America. 106: 21689-94. PMID 19955420 DOI: 10.1073/Pnas.0907623106  0.721
2009 Ghosh SP, Perkins MW, Hieber K, Kulkarni S, Kao TC, Reddy EP, Reddy MV, Maniar M, Seed T, Kumar KS. Radiation protection by a new chemical entity, Ex-Rad: efficacy and mechanisms. Radiation Research. 171: 173-9. PMID 19267542 DOI: 10.1667/Rr1367.1  0.301
2009 Prasad A, Park IW, Allen H, Zhang X, Reddy MV, Boominathan R, Reddy EP, Groopman JE. Styryl sulfonyl compounds inhibit translation of cyclin D1 in mantle cell lymphoma cells. Oncogene. 28: 1518-28. PMID 19198627 DOI: 10.1038/onc.2008.502  0.302
2009 Silverman LR, Odchimar-Reissig R, Navada SC, Ohnuma T, Najfeld V, Wilhelm F, Reddy EP, Holland JF. Effects of a Novel Benzyl Styryl Sulfone Derivative ON 01910.Na On the Myelodysplastic Syndrome (MDS) Derived Clone in Patients Relapsing Following Response to Azacitidine (AzaC) Therapy. Blood. 114: 4839-4839. DOI: 10.1182/Blood.V114.22.4839.4839  0.327
2009 Soper DM, Huang Y, Wilhelm F, Cosenza SC, Reddy EP, Cesano A, Greenberg PL, Fantl WJ. Single Cell Network Profiling (SCNP) to Evaluate the Mechanism of Action of ON 01910.Na, A Novel Clinical Trial Stage Compound. Blood. 114: 3827-3827. DOI: 10.1182/Blood.V114.22.3827.3827  0.39
2008 Reddy MV, Mallireddigari MR, Cosenza SC, Pallela VR, Iqbal NM, Robell KA, Kang AD, Reddy EP. Design, synthesis, and biological evaluation of (E)-styrylbenzylsulfones as novel anticancer agents. Journal of Medicinal Chemistry. 51: 86-100. PMID 18088089 DOI: 10.1021/Jm701077B  0.404
2007 Carbone CJ, Graña X, Reddy EP, Haines DS. p21 loss cooperates with INK4 inactivation facilitating immortalization and Bcl-2-mediated anchorage-independent growth of oncogene-transduced primary mouse fibroblasts. Cancer Research. 67: 4130-7. PMID 17483323 DOI: 10.1158/0008-5472.Can-07-0499  0.359
2007 Park IW, Reddy MV, Reddy EP, Groopman JE. Evaluation of novel cell cycle inhibitors in mantle cell lymphoma. Oncogene. 26: 5635-42. PMID 17369860 DOI: 10.1038/sj.onc.1210350  0.315
2006 Takaesu G, Kang JS, Bae GU, Yi MJ, Lee CM, Reddy EP, Krauss RS. Activation of p38alpha/beta MAPK in myogenesis via binding of the scaffold protein JLP to the cell surface protein Cdo. The Journal of Cell Biology. 175: 383-8. PMID 17074887 DOI: 10.1083/Jcb.200608031  0.385
2006 Kashef K, Xu H, Reddy EP, Dhanasekaran DN. Endodermal differentiation of murine embryonic carcinoma cells by retinoic acid requires JLP, a JNK-scaffolding protein. Journal of Cellular Biochemistry. 98: 715-22. PMID 16619266 DOI: 10.1002/Jcb.20930  0.347
2006 Mangan JK, Tantravahi RV, Rane SG, Reddy EP. Granulocyte colony-stimulating factor-induced upregulation of Jak3 transcription during granulocytic differentiation is mediated by the cooperative action of Sp1 and Stat3. Oncogene. 25: 2489-99. PMID 16518416 DOI: 10.1038/Sj.Onc.1209280  0.624
2005 Reddy HK, Mettus RV, Rane SG, Graña X, Litvin J, Reddy EP. Cyclin-dependent kinase 4 expression is essential for neu-induced breast tumorigenesis. Cancer Research. 65: 10174-8. PMID 16288002 DOI: 10.1158/0008-5472.Can-05-2639  0.374
2005 Kashef K, Lee CM, Ha JH, Reddy EP, Dhanasekaran DN. JNK-interacting leucine zipper protein is a novel scaffolding protein in the Galpha13 signaling pathway. Biochemistry. 44: 14090-6. PMID 16245925 DOI: 10.1021/Bi050604L  0.341
2005 Katuri V, Tang Y, Marshall B, Rashid A, Jogunoori W, Volpe EA, Sidawy AN, Evans S, Blay J, Gallicano GI, Reddy EP, Mishra L, Mishra B. Inactivation of ELF/TGF-β signaling in human gastrointestinal cancer Oncogene. 24: 8012-8024. PMID 16158060 DOI: 10.1038/Sj.Onc.1208946  0.35
2005 Nguyen Q, Lee CM, Le A, Reddy EP. JLP associates with kinesin light chain 1 through a novel leucine zipper-like domain. The Journal of Biological Chemistry. 280: 30185-91. PMID 15987681 DOI: 10.1074/Jbc.M505499200  0.479
2005 Tang Y, Katuri V, Srinivasan R, Fogt F, Redman R, Anand G, Said A, Fishbein T, Zasloff M, Reddy EP, Mishra B, Mishra L. Transforming growth factor-beta suppresses nonmetastatic colon cancer through Smad4 and adaptor protein ELF at an early stage of tumorigenesis. Cancer Research. 65: 4228-37. PMID 15899814 DOI: 10.1158/0008-5472.Can-04-4585  0.327
2005 Reddy NS, Gumireddy K, Mallireddigari MR, Cosenza SC, Venkatapuram P, Bell SC, Reddy EP, Reddy MV. Novel coumarin-3-(N-aryl)carboxamides arrest breast cancer cell growth by inhibiting ErbB-2 and ERK1. Bioorganic & Medicinal Chemistry. 13: 3141-7. PMID 15809149 DOI: 10.1016/J.Bmc.2005.02.051  0.45
2005 Gumireddy K, Reddy MV, Cosenza SC, Boominathan R, Boomi Nathan R, Baker SJ, Papathi N, Jiang J, Holland J, Reddy EP. ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agent. Cancer Cell. 7: 275-86. PMID 15766665 DOI: 10.1016/J.Ccr.2005.02.009  0.333
2005 Gumireddy K, Baker SJ, Cosenza SC, John P, Kang AD, Robell KA, Reddy MV, Reddy EP. A non-ATP-competitive inhibitor of BCR-ABL overrides imatinib resistance. Proceedings of the National Academy of Sciences of the United States of America. 102: 1992-7. PMID 15677719 DOI: 10.1073/Pnas.0408283102  0.353
2005 Mangan JK, Reddy EP. Activation of the Jak3 pathway and myeloid differentiation. Leukemia & Lymphoma. 46: 21-7. PMID 15621777 DOI: 10.1080/10428190400005320  0.709
2004 Lieu YK, Kumar A, Pajerowski AG, Rogers TJ, Reddy EP. Requirement of c-myb in T cell development and in mature T cell function. Proceedings of the National Academy of Sciences of the United States of America. 101: 14853-8. PMID 15466706 DOI: 10.1073/Pnas.0405338101  0.723
2004 Mangan JK, Rane SG, Kang AD, Amanullah A, Wong BC, Reddy EP. Mechanisms associated with IL-6-induced up-regulation of Jak3 and its role in monocytic differentiation. Blood. 103: 4093-101. PMID 14976041 DOI: 10.1182/Blood-2003-06-2165  0.662
2003 Kumar A, Baker SJ, Lee CM, Reddy EP. Molecular mechanisms associated with the regulation of apoptosis by the two alternatively spliced products of c-Myb. Molecular and Cellular Biology. 23: 6631-45. PMID 12944488 DOI: 10.1128/Mcb.23.18.6631-6645.2003  0.54
2003 Kumar A, Lee CM, Reddy EP. c-Myc is essential but not sufficient for c-Myb-mediated block of granulocytic differentiation. The Journal of Biological Chemistry. 278: 11480-8. PMID 12525485 DOI: 10.1074/Jbc.M300080200  0.519
2002 Shore SK, Tantravahi RV, Reddy EP. Transforming pathways activated by the v-Abl tyrosine kinase. Oncogene. 21: 8568-76. PMID 12476303 DOI: 10.1038/Sj.Onc.1206084  0.382
2002 Lee CM, Onésime D, Reddy CD, Dhanasekaran N, Reddy EP. JLP: A scaffolding protein that tethers JNK/p38MAPK signaling modules and transcription factors. Proceedings of the National Academy of Sciences of the United States of America. 99: 14189-94. PMID 12391307 DOI: 10.1073/Pnas.232310199  0.391
2002 Rane SG, Mangan JK, Amanullah A, Wong BC, Vora RK, Liebermann DA, Hoffman B, Graña X, Reddy EP. Activation of the Jak3 pathway is associated with granulocytic differentiation of myeloid precursor cells. Blood. 100: 2753-62. PMID 12351382 DOI: 10.1182/Blood.V100.8.2753  0.705
2002 Rane SG, Reddy EP. JAKs, STATs and Src kinases in hematopoiesis. Oncogene. 21: 3334-58. PMID 12032773 DOI: 10.1038/Sj.Onc.1205398  0.405
2002 Rane SG, Cosenza SC, Mettus RV, Reddy EP. Germ line transmission of the Cdk4(R24C) mutation facilitates tumorigenesis and escape from cellular senescence. Molecular and Cellular Biology. 22: 644-56. PMID 11756559 DOI: 10.1128/Mcb.22.2.644-656.2002  0.365
2001 Kumar A, Reddy EP. Genomic organization and characterization of the promoter region of murine GSTM2 gene. Gene. 270: 221-9. PMID 11404019 DOI: 10.1016/S0378-1119(01)00473-5  0.46
2001 Baker SJ, Sumerson R, Reddy CD, Berrebi AS, Flynn DC, Reddy EP. Characterization of an alternatively spliced AATYK mRNA: expression pattern of AATYK in the brain and neuronal cells. Oncogene. 20: 1015-21. PMID 11314039 DOI: 10.1038/Sj.Onc.1204209  0.659
2001 Vora KA, Lentz VM, Monsell W, Rao SP, Mettus R, Toscani A, Reddy EP, Manser T. The T cell-dependent B cell immune response and germinal center reaction are intact in A-myb-deficient mice. Journal of Immunology (Baltimore, Md. : 1950). 166: 3226-30. PMID 11207276 DOI: 10.4049/Jimmunol.166.5.3226  0.35
2000 Reddy EP, Korapati A, Chaturvedi P, Rane S. IL-3 signaling and the role of Src kinases, JAKs and STATs: a covert liaison unveiled. Oncogene. 19: 2532-47. PMID 10851052 DOI: 10.1038/Sj.Onc.1203594  0.746
2000 Baker SJ, Reddy EP. Cloning of murine G1RP, a novel gene related to Drosophila melanogaster g1. Gene. 248: 33-40. PMID 10806348 DOI: 10.1016/S0378-1119(00)00109-8  0.376
1999 Dermott JM, Reddy MR, Onesime D, Reddy EP, Dhanasekaran N. Oncogenic mutant of Galpha12 stimulates cell proliferation through cycloxygenase-2 signaling pathway. Oncogene. 18: 7185-9. PMID 10602471 DOI: 10.1038/Sj.Onc.1203345  0.331
1999 Oh IH, Reddy EP. The myb gene family in cell growth, differentiation and apoptosis. Oncogene. 18: 3017-33. PMID 10378697 DOI: 10.1038/Sj.Onc.1202839  0.396
1999 Lee CM, Reddy EP. The v-myc oncogene. Oncogene. 18: 2997-3003. PMID 10378695 DOI: 10.1038/Sj.Onc.1202786  0.364
1998 Baker SJ, Reddy EP. Modulation of life and death by the TNF receptor superfamily. Oncogene. 17: 3261-70. PMID 9916988 DOI: 10.1038/Sj.Onc.1202568  0.315
1998 Garriga J, Limón A, Mayol X, Rane SG, Albrecht JH, Reddy EP, Andrés V, Graña X. Differential regulation of the retinoblastoma family of proteins during cell proliferation and differentiation. The Biochemical Journal. 333: 645-54. PMID 9677324 DOI: 10.1042/Bj3330645  0.41
1998 Chaturvedi P, Reddy MV, Reddy EP. Src kinases and not JAKs activate STATs during IL-3 induced myeloid cell proliferation. Oncogene. 16: 1749-58. PMID 9582023 DOI: 10.1038/Sj.Onc.1201972  0.415
1998 Oh IH, Reddy EP. The C-terminal domain of B-Myb acts as a positive regulator of transcription and modulates its biological functions. Molecular and Cellular Biology. 18: 499-511. PMID 9418897 DOI: 10.1128/Mcb.18.1.499  0.36
1997 Gaozza E, Baker SJ, Vora RK, Reddy EP. AATYK: a novel tyrosine kinase induced during growth arrest and apoptosis of myeloid cells. Oncogene. 15: 3127-35. PMID 9444961 DOI: 10.1038/sj.onc.1201575  0.313
1997 Suhasini M, Reddy CD, Reddy EP, DiDonato JA, Pilz RB. cAMP-induced NF-kappaB (p50/relB) binding to a c-myb intronic enhancer correlates with c-myb up-regulation and inhibition of erythroleukemia cell differentiation. Oncogene. 15: 1859-70. PMID 9362453 DOI: 10.1038/Sj.Onc.1201530  0.389
1997 Oh IH, Reddy EP. Murine A-myb gene encodes a transcription factor, which cooperates with Ets-2 and exhibits distinctive biochemical and biological activities from c-myb. The Journal of Biological Chemistry. 272: 21432-43. PMID 9261159 DOI: 10.1074/Jbc.272.34.21432  0.416
1996 Kumar A, Toscani A, Rane S, Reddy EP. Structural organization and chromosomal mapping of JAK3 locus. Oncogene. 13: 2009-14. PMID 8934548  0.365
1996 Leopold LH, Shore SK, Reddy EP. Multi-unit anti-BCR-ABL ribozyme therapy in chronic myelogenous leukemia. Leukemia & Lymphoma. 22: 365-73. PMID 8882949 DOI: 10.3109/10428199609054774  0.326
1996 Patel G, Tantravahi R, Oh IH, Reddy EP. Transcriptional activation potential of normal and tumor-associated myb isoforms does not correlate with their ability to block GCSF-induced terminal differentiation of murine myeloid precursor cells. Oncogene. 13: 1197-208. PMID 8808694  0.338
1995 Grana X, Reddy EP. Cell cycle control in mammalian cells: Role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs) Oncogene. 11: 211-219. PMID 7624138  0.306
1995 Lee KI, Reddy EP, Reddy CD. Cellular factors binding to a novel cis-acting element mediate steroid hormone responsiveness of mouse mammary tumor virus promoter Journal of Biological Chemistry. 270: 24502-24508. PMID 7592667 DOI: 10.1074/Jbc.270.41.24502  0.327
1994 Inoue M, Koga Y, Djordjijevic D, Fukuma T, Reddy EP, Yokoyama MM, Sagawa K. Down-regulation of CD4 molecules by the expression of Nef: a quantitative analysis of CD4 antigens on the cell surfaces. International Immunology. 5: 1067-73. PMID 7902127 DOI: 10.1093/Intimm/5.9.1067  0.318
1994 Rane SG, Reddy EP. JAK3: A novel JAK kinase associated with terminal differentiation of hematopoietic cells Oncogene. 9: 2415-2423. PMID 7518579  0.324
Show low-probability matches.